A PHASE 2, MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DAXIBOTULINUMTOXINA FOR INJECTION (DAXI FOR INJECTION) FOR THE COMBINED TREATMENT OF UPPER FACIAL LINES (GLABELLAR LINES, DYNAMIC FOREHEAD LINES AND LATERAL CANTHAL LINES)
- Registry ID
- 1920201
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- REVANCE THERAPEUTICS, INC.
- Last update
- 2020-01-08
Conditions
- GLABELLAR LINES
- LATERAL CANTHAL LINES
Related clinical trials
- A PHASE III, MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE DOSE OF IPN10200 IN THE IMPROVEMENT OF MODERATE TO SEVERE GLABELLAR LINES IN ADULT PARTICIPANTS
- A DOUBLE-BLINDED RANDOMIZED CONTROLLED STUDY TO COMPARE THE EFFICACY, TIME TO ONSET, AND DURATION OF EFFECT OF BOTULINUM TYPE A TOXINS IN THE TREATMENT OF GLABELLAR FROWN LINES.
- AN OPEN-LABEL, MULTI-CENTER TRIAL TO ASSESS THE SAFETY OF SINGLE AND REPEAT DAXIBOTULINUMTOXINA FOR INJECTION FOR TREATMENT OF MODERATE TO SEVERE GLABELLAR LINES (SAKURA OPEN-LABEL SAFETY)
- A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTI-CENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF DAXIBOTULINUMTOXINA FOR INJECTION TO TREAT MODERATE TO SEVERE GLABELLAR LINES (SAKURA 2)
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, DOSE RANGING, ACTIVE AND PLACEBO CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY AND DURATION OF EFFECT OF RT002, A BOTULINUM TOXIN TYPE A FOR INJECTION, TO TREAT GLABELLAR LINES
- EVALUATION OF THE SAFETY AND EFFICACY OF TREATMENT WITH BOTOX (BOTULIUNUM TOXIN TYPE A) PURIFIED NEUROTOXIN COMPLEX FOR SUBJECTS WITH FOREHEAD AND GLABELLAR FACIAL RHYTIDES
View on source registry